Cargando…
Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel Disease
BACKGROUND: Vaccination is an effective public health measure to combat the SARS-CoV-2 pandemic. However, vaccine “hesitancy” has limited uptake in some, including inflammatory bowel disease (IBD) patients who may have unique concerns influencing uptake. AIM: The aim of the study is to explore attit...
Autores principales: | Zhang, Eva, Gupta, Arun, Al-Ani, Aysha, Macrae, Finlay A., Leong, Rupert W., Christensen, Britt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482530/ https://www.ncbi.nlm.nih.gov/pubmed/36124090 http://dx.doi.org/10.1155/2022/4527844 |
Ejemplares similares
-
Su1491: ATTITUDES AND PREDICTORS OF COVID-19 VACCINE UPTAKE IN INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE
por: Zhang, Eva, et al.
Publicado: (2022) -
The Effects of the COVID Pandemic on Patients with IBD: Lessons Learned and Future Directions
por: Zhang, Eva, et al.
Publicado: (2022) -
Weak SARS-CoV-2 vaccine booster campaign resurrects specter of health care hesistancy
por: Duong, Diana, et al.
Publicado: (2022) -
Benefits and Challenges of Treat-to-Target in Inflammatory Bowel Disease
por: West, Jack, et al.
Publicado: (2023) -
Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.
por: Prentice, Ralley E., et al.
Publicado: (2020)